L6 Pain Medicine Flashcards
Meds for muscle spasms and spasticity
skeletal muscle relaxants
Meds for pain
NSAIDs, opioids, acetaminophen, cannabinoids
Meds for pain and inflammation
NSAIDs and glucocorticoids
Meds for OA and RA
NSAIDs, acetaminophen, opioids, SAIDs, DMARDs, viscosupplmentation
Pharmacodynamics
effect of the drug on the body
Pharmacokinetics
effects of body on the drug
Absorption, Distribution, Metabolism, Excretion, Elimination
Intracellular nuclear receptors
directly affects gene function
slowest
Metabotropic receptors
activates a second messenger system
Ionotropic receptors
opening an ion channel and changing membrane permeability or membrane potential
fastest
Affinity
amount of attraction between drug and receptor
Selective
drug only binds to 1 receptor subtype and produces a single response
no drug is perfectly selective
Agonist
drug binds to receptor and produces change in cell function (affinity and efficacy)
Partial agonist
less efficacy, varying levels of affinity
Full agonist
high efficacy, high affinity
Antagonist
drug binds to receptor but produces no change in cell function
only affinity, no efficacy
Spasticity
result of UMN lesion
increased muscle tone, hyperactive velocity dependent stretch reflex, clonus
Spasms
results of local musculoskeletal injury
nociceptive stimuli eventually leads to increased tonic muscle contraction
Skeletal muscle relaxants and CNS
all but two relaxants ultimately decrease neural excitability at the “final common pathway”
most muscle relaxers work upstream, having impacts on the CNS that controls the muscle
causes decreased excitability of all neurons with GABAA receptors. causes a general slowing of the CNS, or sedation
Antispasm agents
Benzodiazepines (BZDs)
Polysynaptic inhibitors
Botulinum toxin
Benzodiazepines (BZDs)
agonists at GABAA ion channel receptor complex
after it binds to the receptor, CL flow through channel increases, hyperpolarizing the neuron
Receptors for BZDs are present throughout the CNS
causes muscle relaxation and decreased arousal
also used for insomnia and anxiety
ADRs and Interactions of Benzos
ADRs: muscle weakness, ataxia, drowsiness, confusion, dependency, abuse
Interactions: Alcohol and other depressants. Grapefruit juice
Tolerance
higher dose required for same effect
Withdrawal
occurs with abrupt discontinuation
irritability, insomnia, muscle cramps
Benzos and Half Lives
can have up to a 30 to 60 hour half life (diazepam/valium)
would be about 150-300 hours to be eliminated from the system
half lives can increase in adults that are older
usually prescribed for short term use
Polysynaptic inhibitors
includes cyclobezaprine
exact MOA is not well understood
all drugs in this group decrease alpha motor neuron stimulation
all produce general CNS depressant effect
onset of action is usually 30 to 60 min, and lasts up to 24 hours
Botulinum Toxin
-produced by bacteria
-when injected into a muscle, it blocks AcH release at NMJ
-paralysis is dose related and transient
-recovery occurs when new nerve terminals regenerate at injection site. Takes about 3 months
Clinical uses of BTX
FOCAL DYSTONIAS
SPASTICITY
INVOLUNTARY MUSCLE ACTIVITY
NYSTAGMUS
CHRONIC PAIN
urinary incontinence
Lots of off label uses, like LBP and neck pain, cosmetic use
Uses and Limitations of BTX
Results in paralysis of injected muscle, uninjected are unaffected
Repeated injections necessary
limited # of muscles that can be injected
misinjections
Drugs used for muscle spasticity
GABA receptor agonists
gabapentin
alpha adrenergic receptor agonist
peripheral acting drugs
Baclofen (GABA agonist)
Pharmacodynamics: binding causes neuron hyperpolarization by increasing K flow out of cell. Results in inhibition of alpha motor neuron
Clinical uses of Baclofen
on label: spasticity, for SCI and MS
off label: LBP, trigeminal neuralgia, cluster headache
Routes of Administration for Baclofen
oral: systemic ADRs that are limiting
intrathecal: fewer systemic ADRs. Predominantly for LE spasiticty . Limits bending and twisting